Randomized phase II study of everolimus (E), leuprolide plus letrozole (LL), and E plus LL (ELL) in patients (pts) with unresectable fibrolamellar carcinoma (FLC) Meeting Abstract


Authors: Abou-Alfa, G. K.; Mayer, R. J.; Cosgrove, D.; Capanu, M.; Choti, M. A.; Atreya, C. E.; Ang, C.; Kelley, R. K.; Do, R. K. G.; Gordan, J. D.; Zhu, A. X.; Ly, M.; Nolan, P.; Lubin, L.; Harding, J. J.; Saltz, L.; Venook, A. P.
Abstract Title: Randomized phase II study of everolimus (E), leuprolide plus letrozole (LL), and E plus LL (ELL) in patients (pts) with unresectable fibrolamellar carcinoma (FLC)
Meeting Title: 2015 Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 33
Issue: 15 Suppl.
Meeting Dates: 2015 May 29-Jun 2
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2015-05-20
Language: English
ACCESSION: WOS:000358036902918
PROVIDER: wos
Notes: Meeting Abstract: e15149 -- Source: Wos